FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

29930611000001102: Naloxegol oxalate (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2017. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    93229101000001113 Naloxegol oxalate (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    93229201000001118 Naloxegol oxalate en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Naloxegol oxalate Is a Substance with opioid receptor antagonist mechanism of action false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Naloxegol 12.5mg tablets Has specific active ingredient False Naloxegol oxalate Inferred relationship Existential restriction modifier
    Naloxegol 25mg tablets Has specific active ingredient False Naloxegol oxalate Inferred relationship Existential restriction modifier
    Moventig 12.5mg tablets (AstraZeneca UK Ltd) Has specific active ingredient False Naloxegol oxalate Inferred relationship Existential restriction modifier
    Moventig 25mg tablets (AstraZeneca UK Ltd) Has specific active ingredient False Naloxegol oxalate Inferred relationship Existential restriction modifier
    Naloxegol 25mg tablets 30 tablet Has specific active ingredient False Naloxegol oxalate Inferred relationship Existential restriction modifier
    Naloxegol 12.5mg tablets 30 tablet Has specific active ingredient False Naloxegol oxalate Inferred relationship Existential restriction modifier
    Moventig 12.5mg tablets (AstraZeneca UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Naloxegol oxalate Inferred relationship Existential restriction modifier
    Moventig 25mg tablets (AstraZeneca UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Naloxegol oxalate Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start